We aspire, as part of our vision, to be a trusted leader in changing the practice of medicine. To realize this vision, we need to earn and maintain the trust of patients, associates, healthcare partners, shareholders and the society we serve.
As a global leader in healthcare, we have a responsibility to serve as a role model in how we conduct our business. We continually review and strengthen our policies and practices to meet and exceed the expectations of our stakeholders, and strive to adhere to high business, clinical and ethical standards.
Our aim is to prevent issues from occurring, drive personal accountability for behaviors, and generate learnings that can be applied across the organization.
In August 2014, we created a new position of Chief Ethics and Compliance Officer, reporting to the CEO – elevating the Compliance function to the highest levels in the company. On May 1, 2016, Shannon Klinger, formerly General Counsel for Sandoz, was appointed as Novartis Chief Ethics & Compliance Officer and Head Litigation. Shannon will continue to strengthen our commitment to integrity and compliance and embed a culture of high performance with integrity throughout the organization.
We do not tolerate unethical behavior by our associates anywhere, and we will take all necessary steps to ensure compliance with our Code of Conduct and all applicable laws. At the same time, we know there are potential pockets of bad behavior in a global business with more than 120 000 associates, and we work to take swift action when this occurs.
We have further strengthened our compliance system by adding country and global compliance risk assessments for marketing and sales. We work to identify and mitigate risk exposure proactively so it can be reviewed and discussed at a management level.
Our goal is to maintain consistent standards of business practices across Novartis, ultimately enabling us to provide the best possible care for patients globally.
Novartis seeks to collaborate with Healthcare Professionals and Healthcare Organizations in the interest of patients. As an industry we make payments or ‘transfers of value’ to Healthcare Professionals and Organizations to compensate them for the time spent working with us.